INTRAHEPATIC EXPRESSION OF PD-1, PD-L1 AND PD-L2 IN CHRONIC HEPATITIS B PATIENTS

被引：0
|
作者：
Chen, J. [1 ]
Lan, M. -D. [2 ]
Wu, X. -J. [1 ]
Zhao, J. -M. [3 ]
Lan, Z. -W. [2 ]
Wang, G-Q [1 ]
机构：
[1] Peking Univ, Hosp 1, Beijing 100871, Peoples R China
[2] Peking Di Tan Hosp, Beijing, Peoples R China
[3] 302 Hosp, Beijing, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 50卷
关键词：
D O I：
10.1016/S0168-8278(09)60558-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
556
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 50 条
  • [31] Currently Used Laboratory Methodologies for Assays Detecting PD-1, PD-L1, PD-L2 and Soluble PD-L1 in Patients with Metastatic Breast Cancer
    Jeong, Seri
    Lee, Nuri
    Park, Min-Jeong
    Jeon, Kibum
    Song, Wonkeun
    CANCERS, 2021, 13 (20)
  • [32] Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcoma
    Miyake, Makito
    Oda, Yuki
    Nishimura, Nobutaka
    Morizawa, Yosuke
    Ohnishi, Sayuri
    Hatakeyama, Kinta
    Fujii, Tomomi
    Hori, Shunta
    Gotoh, Daisuke
    Nakai, Yasushi
    Anai, Satoshi
    Torimoto, Kazumasa
    Tsukamoto, Shinji
    Fujii, Hiromasa
    Kido, Akira
    Honoki, Kanya
    Matsumura, Yoshiaki
    Okajima, Eijiro
    Tanaka, Nobumichi
    Fujimoto, Kiyohide
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [33] IDENTIFICATION OF PROGRAMMED DEATH 1 (PD-1) AND ITS COGNATE LIGANDS (PD-L1, PD-L2) IN THE PEKIN DUCK AND EXPRESSION ANALYSIS IN THE DUCK HEPATITIS B MODEL
    Yao, Q.
    Fischer, K. P.
    Tyrrell, L.
    Gutfreund, K. S.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S319 - S319
  • [34] The PD-1 pathway in systemic lupus erythematosus: The Ligands of PD-1, PD-L1 and PD-L2, are also susceptibility factors.
    Abelson, AK
    Johansson, C
    Kozyrev, S
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S203 - S203
  • [35] Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma
    Lee, Min Young
    Park, Chan-jeoung
    Cho, Young-Uk
    You, Eunkyoung
    Jang, Seongsoo
    Lee, Jung-Hee
    Hong, Jung Yong
    Yoon, Dok Hyun
    Suh, Cheolwon
    BLOOD, 2017, 130
  • [36] Expression of programmed death (PD)-1 and PD-1 ligands (PD-L1, PD-L2) in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
    Bertsias, G.
    Raptopoulou, A.
    Coutala, E.
    Mamoulaki, M.
    Kritikos, H.
    Sidiropoulos, P.
    Boumpas, D. T.
    ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 1) : S55 - S55
  • [37] Expression of programmed death (PD)-1 and PD-1 ligands (PD-L1, PD-L2) in peripheral blood mononuclear cells of patients with systemic lupus erythematosus
    G Bertsias
    A Raptopoulou
    E Coutala
    M Mamoulaki
    H Kritikos
    P Sidiropoulos
    DT Boumpas
    Arthritis Research & Therapy, 7
  • [38] Gene expression and soluble protein level of PD-1 and its ligands (PD-L1 and PD-L2) in endometrial cancer
    Yusof, Mohd Nazzary Mamat
    Chew, Kah Teik
    Kampan, Nirmala Chandralega
    Hafizz, Abdul Muzhill Hannaan Abdul
    Shafiee, Mohamad Nasir
    PLOS ONE, 2025, 20 (03):
  • [39] Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2
    Zak, Krzysztof M.
    Grudnik, Przemyslaw
    Magiera, Katarzyna
    Domling, Alexander
    Dubin, Grzegorz
    Holak, Tad A.
    STRUCTURE, 2017, 25 (08) : 1163 - 1174
  • [40] Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer
    Jiang, Siqing
    Li, Xin
    Huang, Lihua
    Xu, Zhensheng
    Lin, Jinguan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345